BIOMAT Database Logo BIOMAT Database Logo

Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities. 2010

Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Université de Nantes, Nantes Atlantique Universités, Laboratoire de Chimie Thérapeutique, Cibles et Médicaments des Infections, de l'Immunité et du Cancer, IICiMed UPRES EA 1155, Faculté de Pharmacie, Nantes, France.

N-aryl-3-(indol-3-yl)propanamides were synthesized and their immunosuppressive activities were evaluated. This study highlighted the promising potency of 3-[1-(4-chlorobenzyl)-1H-indol-3-yl]-N-(4-nitrophenyl)propanamide 15 which exhibited a significant inhibitory activity on murine splenocytes proliferation assay in vitro and on mice delayed-type hypersensitivity (DTH) assay in vivo.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.
February 1999, Journal of medicinal chemistry,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
September 2009, Bioorganic & medicinal chemistry,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Synthesis of 3-(5-amino-1H-1,2,4-triazol-3-yl)propanamides and their tautomerism.
June 2018, RSC advances,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Synthesis and immunomodulating activity of condensed N-aryl-2-cyano-3-oxo-3-pyrazolyl-propanamides.
January 1991, Farmaco (Societa chimica italiana : 1989),
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Synthesis and antifungal activities of 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazinan-4-ones.
January 2013, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
2-Aryl-3H-indol-3-ones: synthesis, electrochemical behaviour and antiplasmodial activities.
May 2014, European journal of medicinal chemistry,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
2-amido-3-(1H-indol-3-yl)-N-substituted-propanamides as a new class of falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies.
January 2009, Molecules (Basel, Switzerland),
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Rapid access to N-(indol-2-yl)amides and N-(indol-3-yl)amides as unexplored pharmacophores.
January 2017, Organic & biomolecular chemistry,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators.
June 2010, Bioorganic & medicinal chemistry,
Francis Giraud, and Pascal Marchand, and Delphine Carbonnelle, and Michael Sartor, and François Lang, and Muriel Duflos
Synthesis and analgesic activity of N-aryl/arylalkyl-N-[2-(1-pyrrolidinyl)cyclohexyl]propanamides.
July 1999, Die Pharmazie,
Copied contents to your clipboard!